Kangji Medical Holdings Limited ( (HK:9997) ) just unveiled an update.
Kangji Medical Holdings Limited announced that its associate, Hangzhou Weijing Medical Robot Co., Ltd., has received regulatory approval from China’s National Medical Products Administration for its four-arm laparoscopic surgical robot. This approval marks a significant milestone in Weijing Medical’s commercialization efforts and strengthens Kangji Medical’s strategic position in the minimally invasive surgery market. The company plans to leverage its sales, distribution, and manufacturing capabilities to support the development and commercialization of Weijing Medical’s surgical robotic systems.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a leading medical device platform in China, specializing in minimally invasive surgical instruments and consumables. The company has expanded into the laparoscopic robotics field through strategic investments, reinforcing its core competitiveness in the minimally invasive surgery sector.
Average Trading Volume: 1,460
Technical Sentiment Signal: Sell
Current Market Cap: €917M
Learn more about 9997 stock on TipRanks’ Stock Analysis page.